Stakeholders are pushing even harder now for concrete action to address critical issues plaguing the current EU medtech regulatory framework. This follows the meeting of European health ministers at the Council of the EU in early December, and builds on the European Parliament resolution from October.
A key voice in this discussion is the German medical technology association (BVMed), which has been
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?